WELL (Welltower Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by WELL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-27 | Andrew Gundlach | Director | Buy | — | — |
| 2026-08-24 | DENNIS G LOPEZ | Director | A | — | — |
| 2026-06-29 | Shankh Mitra | CEO | MIXED | — | — |
| 2026-05-27 | Shankh Mitra | CEO | G | — | — |
| 2026-05-26 | DENNIS G LOPEZ | Director | A | — | — |
| 2026-05-05 | KENNETH J BACON | Director | C | — | — |
| 2026-05-01 | Shankh Mitra | CEO | G | — | — |
| 2026-02-27 | KENNETH J BACON | Director | A | — | — |
| 2026-02-27 | Karen B DeSalvo | Director | A | — | — |
| 2026-02-27 | DENNIS G LOPEZ | Director | A | — | — |
| 2026-02-27 | Ade J. Patton | Director | A | — | — |
| 2026-02-27 | Sergio Rivera | Director | A | — | — |
| 2026-02-27 | Johnese Spisso | Director | A | — | — |
| 2026-02-27 | Andrew Gundlach | Director | A | — | — |
| 2026-02-27 | KATHRYN M SULLIVAN | Director | A | — | — |
| 2026-02-18 | Joshua Fieweger | SVP, Chief Accounting Officer | A | — | — |
| 2026-02-18 | Matthew Grant Mcqueen | Chief Legal Officer | G | — | — |
| 2026-02-18 | John F. Burkart | Vice Chairman and COO | A | — | — |
| 2026-02-18 | Nikhil Chaudhri | Co-President and CIO | A | — | — |
| 2026-02-18 | Timothy McHugh | Co-President and CFO | A | — | — |
| 2026-02-18 | Shankh Mitra | CEO | A | — | — |
| 2026-01-20 | Joshua Fieweger | SVP, Chief Accounting Officer | F | — | — |
| 2026-01-05 | Andrew Gundlach | Director | A | — | — |
| 2026-01-05 | DENNIS G LOPEZ | Director | A | — | — |
| 2025-12-16 | Timothy McHugh | Co-President and CFO | G | — | — |
| 2025-12-02 | Shankh Mitra | CEO | A | — | — |
| 2025-12-02 | Nikhil Chaudhri | Co-President and CIO | A | — | — |
| 2025-12-02 | John F. Burkart | Vice Chairman and COO | A | — | — |
| 2025-12-02 | Timothy McHugh | Co-President and CFO | A | — | — |
| 2025-12-02 | Joshua Fieweger | SVP, Chief Accounting Officer | A | — | — |
| 2025-12-02 | Matthew Grant Mcqueen | Chief Legal Officer | A | — | — |
| 2025-11-21 | DENNIS G LOPEZ | Director | A | — | — |
| 2025-10-31 | Shankh Mitra | CEO | A | — | — |
| 2025-10-31 | Nikhil Chaudhri | Co-President and CIO | A | — | — |
| 2025-10-31 | Timothy McHugh | Co-President and CFO | A | — | — |
| 2025-10-31 | John F. Burkart | Vice Chairman and COO | A | — | — |
| 2025-10-31 | Matthew Grant Mcqueen | Chief Legal Officer | A | — | — |
| 2025-08-25 | DENNIS G LOPEZ | Director | A | — | — |
| 2025-07-02 | Andrew Gundlach | Director | Buy | — | — |
| 2025-06-17 | Shankh Mitra | CEO | MIXED | — | — |
| 2025-06-11 | Shankh Mitra | CEO | Sell | — | — |
| 2025-06-10 | Shankh Mitra | CEO | Sell | — | — |
| 2025-06-10 | Timothy McHugh | Co-President and CFO | Sell | — | — |
| 2025-06-10 | John F. Burkart | Vice Chairman and COO | Sell | — | — |
| 2025-06-10 | Matthew Grant Mcqueen | Chief Legal Officer | Sell | — | — |
| 2025-06-10 | Nikhil Chaudhri | Co-President and CIO | Sell | — | — |
| 2025-05-23 | DENNIS G LOPEZ | Director | A | — | — |
| 2025-05-01 | Karen B DeSalvo | Director | Sell | — | — |
| 2025-03-10 | Karen B DeSalvo | Director | A | — | — |
| 2025-03-10 | DENNIS G LOPEZ | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | — | 423,185 | — |
| — | Chairman & CEO | 338,415 | — |
| — | EVP-COO | 122,414 | — |
| — | EVP and CFO | 119,319 | — |
| — | EVP - Chief Investment Officer | 102,563 | — |
| — | CEO | 76,556 | — |
| — | EVP-Head Human Cap.&Corp.Secy. | 63,256 | — |
| — | Director | 60,469 | — |
| — | Director | 49,223 | — |
| — | Chief Financial Officer | 48,094 | — |
| — | EVP-Business Development | 44,478 | — |
| — | — | 29,989 | — |
| — | Chief Legal Officer | 26,881 | — |
| — | Director | 26,611 | — |
| — | Director | 25,000 | — |
| — | Co-President and CFO | 23,424 | — |
| — | SVP, Chief Accounting Officer | 21,269 | — |
| — | Director | 19,161 | — |
| — | Director | 18,597 | — |
| — | Director | 18,468 | — |
| — | Director | 16,057 | — |
| — | Director | 14,306 | — |
| — | Director | 13,588 | — |
| — | Director | 12,369 | — |
| — | Director | 10,830 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the WELL quote page; the site-wide leaderboard is on the insider transactions hub.